Dr. Giulia Falconi is a biomedical researcher with a PhD in ?Technological Applications in Oncohematology? from Universit? Cattolica del Sacro Cuore in Rome. She is currently a Post-Doctoral Fellow at the University of Rome Tor Vergata, where her work focuses on the role of the bone marrow microenvironment and somatic mutations in the pathogenesis of therapy-related myeloid neoplasms (t-MN) and myelodysplastic syndromes (MDS).
Her research expertise includes molecular and cell biology techniques such as PCR, NGS, ddPCR, and mesenchymal stem cell culture. Dr. Falconi has contributed to over 25 peer-reviewed publications and has presented her findings at numerous national and international conferences.
She is a recipient of several prestigious awards, including the Fondazione Umberto Veronesi Postdoctoral Fellowship (2019), and is an active member of SIES and SIBioC. Her scientific work supports the advancement of prognostic and therapeutic approaches in hematologic malignancies.